EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 22-Jun-2026 04:16 ET (22-Jun-2026 08:16 GMT/UTC)

6-Jan-2026

MIT study shows AI-generated sensors open new paths for early cancer detection

Massachusetts Institute of Technology
Peer-Reviewed Publication

A new AI model designs peptides (short proteins) that are targeted by enzymes called proteases, which are overactive in cancer cells. Nanoparticles coated with these peptides can act as sensors that signal if cancer-linked proteases are present in the body.

Journal: Nature Communications
Funder: “la Caixa” Foundation, the Ludwig Center at MIT, the Marble Center for Cancer Nanomedicine

6-Jan-2026

Cornell-developed particles supercharge cancer immunotherapy

Cornell University
Peer-Reviewed Publication

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to rally the immune system against melanoma and dramatically improve the effectiveness of cancer immunotherapy, according to a new study led by Weill Cornell Medicine and Cornell Engineering researchers.

Journal: Nature Nanotechnology

6-Jan-2026

UH pharmacy researcher receives $900,000 CPRIT grant to develop nanodrug that boosts immune system to fight cancer

University of Houston
Grant and Award Announcement

Accelerating advancements in cancer prevention and cures, a University of Houston pharmacologist has received a grant from the Cancer Prevention and Research Institute of Texas to develop a drug that could offer lasting tumor control and improved survival for patients with pancreatic and lung cancers.

6-Jan-2026

New evidence reveals streptococcus anginosus drives gastric cancer development

BGI Genomics
Peer-Reviewed Publication

A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus anginosus (Sa). The research shows that methionine metabolites produced by this bacterium can significantly contribute to the development of gastric cancer.

This finding deepens the understanding of the gut microbiome’s role in cancer and opens new paths for microbiota-targeted prevention strategies.

Journal: Gut

6-Jan-2026

Mapping cancer’s weak spots reveals new precision targets for breast cancer

China Anti-Cancer Association
Peer-Reviewed Publication

Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies.

Journal: Cancer Biology & Medicine

6-Jan-2026

Supramolecular self-assembly with dual functions of GSH-synthesis inhibition and consumption for efficient chemodynamic therapy

KeAi Communications Co., Ltd.
Peer-Reviewed Publication

In this system, Fc could convert overexpressed H₂O₂ to produce ·OH. Importantly, Cur could form dynamic boronate ester bonds with BA, and be encapsulated in SPSAs-1 through responsive chemical bond to form SPSAs-2. The acidic microenvironment and excessive H₂O₂ within tumor cells cause the dissociation of boronate ester bonds and β-CD/Fc complexes, releasing Cur. As a result, the GSH level could be reduced through the combination of the BA-induced GSH consumption and Cur-induced inhibition of TrxR activation, further enhancing CDT efficacy.

Journal: Glycoscience & Therapy
Funder: Top Young Talented Scientist in Shanxi Province, National Natural Science Foundation of China, Shaanxi Fundamental Science Research Project of Chemistry & Biology

5-Jan-2026

A nuclear target to revive anti-tumor immunity

Ludwig Institute for Cancer Research
Peer-Reviewed Publication

Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by which a metabolic derivative of vitamin A—all-trans retinoic acid—compromises both the body’s normal anti-cancer immune response and, in a different context, the efficacy of a promising type of cancer vaccine.

Journal: Nature Immunology
Funder: Ludwig Institute for Cancer Research, New Jersey Health Foundation, Brewster Foundation, the Susan Komen Foundation, Breast Cancer Research Foundation, American Cancer Society, National Science Foundation

5-Jan-2026

Retrotransposon drives cancer by altering 3D genome structure

St. Jude Children's Research Hospital
Peer-Reviewed Publication

Scientists at St. Jude Children’s Research Hospital found that tumor cells use LINE-1 retrotransposons to restructure the genome to promote cancer gene expression.

Journal: Cancer Discovery

5-Jan-2026

New cervical cancer screening guidelines from the US Department of Health and Human Services

JAMA Network
Peer-Reviewed Publication

This Viewpoint discusses past cervical cancer screening guidelines and presents new Women’s Preventive Services guidelines issued by the U.S. Department of Health and Human Services.

Journal: JAMA

5-Jan-2026

UH researcher receives nearly $1M to advance lupus diagnosis and treatment

University of Houston
Grant and Award Announcement

With nearly $1 million in federal funding, a University of Houston researcher will study the connection between an enzyme found in cancerous tumors and immune cells of lupus patients — innovative research that could transform how lupus is diagnosed and treated.